Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Appl Microbiol Biotechnol ; 87(4): 1221-35, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20532758

ABSTRACT

Living organisms produce a myriad of molecules to protect themselves from fungal pathogens. This review focuses on antifungal proteins from plants and mushrooms, many of which are components of the human diet or have medicinal value. Plant antifungal proteins can be classified into different groups comprising chitinases and chitinase-like proteins, chitin-binding proteins, cyclophilin-like proteins, defensins and defensin-like proteins, deoxyribonucleases, embryo-abundant protein-like proteins, glucanases, lectins, lipid transfer proteins, peroxidases, protease inhibitors, ribonucleases, ribosome-inactivating proteins, storage 2S albumins, and thaumatin-like proteins. Some of the aforementioned antifungal proteins also exhibit mitogenic activity towards spleen cells, nitric oxide inducing activity toward macrophages, antiproliferative activity toward tumor cells, antibacterial activity, and inhibitory activity toward HIV-1 reverse transcriptase. In contrast to the large diversity of plant antifungal proteins, only a small number of mushroom antifungal proteins have been reported. Mushroom antifungal proteins are distinct from their plant counterparts in N-terminal sequence. Nevertheless, some of the mushroom antifungal proteins have been shown to inhibit HIV-1 reverse transcriptase activity and tumor cell proliferation.


Subject(s)
Agaricales/metabolism , Antifungal Agents/metabolism , Drug Therapy , Fungal Proteins/metabolism , Plant Proteins/metabolism , Plants/metabolism , Agaricales/chemistry , Agaricales/genetics , Animals , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Fungal Proteins/pharmacology , Fungal Proteins/therapeutic use , Fungi/drug effects , Humans , Plant Proteins/pharmacology , Plant Proteins/therapeutic use , Plants/genetics , Plants/microbiology
2.
Biochem Biophys Res Commun ; 338(3): 1654-60, 2005 Dec 23.
Article in English | MEDLINE | ID: mdl-16263078

ABSTRACT

Infection of SARS-associated coronavirus (SARS-CoV) induced a strong anti-nucleocapsid (anti-N) antibody response. However, the pathophysiological significance of the anti-N antibodies in SARS pathogenesis is largely unknown. To profile the anti-N antibodies, a phage-displayed scFv library was prepared from mice immunized with heat-inactivated SARS-CoV-infected Vero E6 cell lysate. Specific anti-N scFvs were isolated by panning against a recombinant nucleocapsid protein and reactivity was confirmed with phage-ELISA. Sequence analysis indicated that two of the isolated anti-N scFv clones were identical and displayed a high homology with an scFv specific for interleukin 11 (IL-11), an anti-inflammatory cytokine derived from bone marrow stroma cells. In a neutralization assay, IL-11-induced STAT 3 phosphorylation in rat intestinal epithelial IEC-18 cells was completely suppressed by the anti-N scFv clone L9N01.


Subject(s)
Antibodies, Viral/immunology , Interleukin-11/immunology , Nucleocapsid Proteins/immunology , Severe acute respiratory syndrome-related coronavirus/immunology , Animals , Base Sequence , Cell Line , Chlorocebus aethiops , Cross Reactions/immunology , Mice , Molecular Sequence Data , Nucleocapsid Proteins/chemistry , Rats , Severe acute respiratory syndrome-related coronavirus/chemistry , Sequence Alignment , Sequence Homology, Nucleic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...